Market Exclusive

Analyst Activity – HC Wainwright Reiterates Buy on Anthera Pharmaceuticals (NASDAQ:ANTH)

Analyst Ratings For Anthera Pharmaceuticals (NASDAQ:ANTH)

Today, HC Wainwright reiterated its Buy rating on Anthera Pharmaceuticals (NASDAQ:ANTH).

Some recent analyst ratings include

Recent Insider Trading Activity For Anthera Pharmaceuticals (NASDAQ:ANTH)
Anthera Pharmaceuticals (NASDAQ:ANTH) has insider ownership of 2.08% and institutional ownership of 28.12%.

Recent Trading Activity for Anthera Pharmaceuticals (NASDAQ:ANTH)
Shares of Anthera Pharmaceuticals closed the previous trading session at with 2.5999999046325684 shares trading hands.

Exit mobile version